Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+3.91%+4.15%+102.83%+549.67% 49.27B
+1.21%-3.54%+13.44%+54.84% 25.57B
+1.57%-1.02%-14.08%-37.62% 6.72B
0.00%+2.41%+2.00%+162.67% 5.94B
-0.14%-0.32%+15.61%+63.23% 3.33B
+5.25%+4.36%-27.60%+1,761.83% 2.68B
+6.29%+5.93%+131.28%+34.18% 2.37B
+1.61%+6.10%+35.44%+47.48% 2.26B
+6.06%+4.21%-15.73%-51.47% 1.87B
Average +2.58%+2.21%+27.02%+287.20% 10B
Weighted average by Cap. +2.78%+1.62%+56.67%+342.17%

Financials

2023 2024
Net sales 346M 4.1M 3.55M 3.35M 3.04M 5.71M 393M 5.75M 40.05M 15.43M 199M 15.4M 15.06M 634M 426M 5.05M 4.37M 4.13M 3.74M 7.02M 484M 7.07M 49.29M 18.99M 245M 18.96M 18.54M 780M
Net income -35.17M -417K -361K -341K -309K -580K -39.94M -584K -4.07M -1.57M -20.26M -1.57M -1.53M -64.41M -13.29M -157K -136K -129K -117K -219K -15.09M -221K -1.54M -593K -7.66M -591K -578K -24.34M
Net Debt - -
Logo GENETICO
TsGRM Genetiko PAO is a Russia-based company primarily engaged in provision of medical services. The Company comprises laboratory and production complexes that provide a range of medical genetic services for both doctors and patients. The Company conducts complex genetic diagnostics of hereditary diseases and reproductive disorders. The Company's structure consists of four laboratories: Next-Generation Sequencing (NGS) laboratory; Non-Invasive Prenatal Testing (NIPT) laboratory; Oncogenetics laboratory; and Genotyping laboratory.
Employees
-
  1. Stock Market
  2. Stocks
  3. GECO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!